Higher endocannabinoid levels appeared to buffer the link between childhood trauma and inflammation in people with borderline personality disorder
In a study of 48 women with borderline personality disorder and 31 healthy controls, higher endocannabinoid levels appeared to weaken the association between adverse childhood experiences and the inflammatory marker IL-6.
Quick Facts
What This Study Found
People with BPD had higher IL-6 levels than healthy controls. Endocannabinoids (AEA and 2-AG) correlated positively with IL-6 across all participants. The link between childhood trauma and IL-6 was strongest in participants with low endocannabinoid levels, while those with the highest endocannabinoid levels showed no correlation between trauma and inflammation.
Key Numbers
48 females with BPD and 31 healthy controls. Higher IL-6 in BPD group. AEA and 2-AG positively correlated with IL-6. Trauma-IL-6 correlation strong in lowest three endocannabinoid quartiles (n=57) but absent in highest quartile (n=19). Recent suicide attempts significantly higher in high-IL-6 group (OR=0.22).
How They Did This
Cross-sectional analysis of 48 females with borderline personality disorder and 31 matched healthy controls. Adverse childhood experiences were assessed via the Childhood Trauma Questionnaire. Plasma IL-6, anandamide (AEA), and 2-AG concentrations were measured.
Why This Research Matters
This study connects three systems rarely examined together: childhood trauma, the immune system, and the endocannabinoid system. The finding that endocannabinoids may buffer the trauma-inflammation link suggests a potential mechanism for why some trauma survivors develop inflammatory conditions and others do not.
The Bigger Picture
The endocannabinoid system is increasingly recognized as a stress buffer. This study provides human evidence that endocannabinoids may modulate how childhood adversity translates into adult inflammation, with implications for both trauma recovery and mental health treatment.
What This Study Doesn't Tell Us
Cross-sectional design cannot establish causality. Female-only sample. Small sample sizes, especially in subgroup analyses. Single time-point measurements of endocannabinoids and IL-6 may not capture dynamic fluctuations.
Questions This Raises
- ?Could endocannabinoid-boosting interventions reduce inflammation in trauma survivors?
- ?Do these patterns hold in males with BPD?
- ?Is the suicide-IL-6 association a direct pathway or confounded by other factors?
Trust & Context
- Key Stat:
- Trauma-inflammation link absent in those with highest endocannabinoid levels
- Evidence Grade:
- Preliminary: small cross-sectional study with female-only sample and exploratory subgroup analyses.
- Study Age:
- Published 2026.
- Original Title:
- The role of the endocannabinoid system in the interplay of adverse childhood experiences and interleukin 6 in individuals with borderline personality disorder.
- Published In:
- Psychopharmacology, 243(2), 315-324 (2026)
- Authors:
- Spohrs, Jennifer, Kühnle, Valentin, Reber, Stefan O, Mikusky, David, Sanhüter, Niklas, Macchia, Ana, Nickel, Sandra, Abler, Birgit
- Database ID:
- RTHC-08639
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Can the endocannabinoid system protect against trauma-related inflammation?
This study found that people with the highest endocannabinoid levels showed no correlation between childhood trauma and the inflammatory marker IL-6, while those with lower levels showed a strong link.
Is inflammation linked to suicide risk in BPD?
In this study, the number of recent suicide attempts was significantly higher among those with elevated IL-6 levels, though the study cannot establish whether inflammation directly contributes to suicide risk.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-08639APA
Spohrs, Jennifer; Kühnle, Valentin; Reber, Stefan O; Mikusky, David; Sanhüter, Niklas; Macchia, Ana; Nickel, Sandra; Abler, Birgit. (2026). The role of the endocannabinoid system in the interplay of adverse childhood experiences and interleukin 6 in individuals with borderline personality disorder.. Psychopharmacology, 243(2), 315-324. https://doi.org/10.1007/s00213-025-06809-8
MLA
Spohrs, Jennifer, et al. "The role of the endocannabinoid system in the interplay of adverse childhood experiences and interleukin 6 in individuals with borderline personality disorder.." Psychopharmacology, 2026. https://doi.org/10.1007/s00213-025-06809-8
RethinkTHC
RethinkTHC Research Database. "The role of the endocannabinoid system in the interplay of a..." RTHC-08639. Retrieved from https://rethinkthc.com/research/spohrs-2026-the-role-of-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.